Lykan Bioscience is a contract development and manufacturing services organization (CDMO) focused on cell-based therapies. The state-of-the-art, purpose-built facility offers 14 independent manufacturing suites is uniquely designed to be cGMP compliant and support clinical and commercial manufacturing. Sold to RoslinCT, a GHO-backed portfolio company.